DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate.

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Category AI
Palladyne AI Corp ( $PDYN ) Deep Dive after Q4 & 2025 Full year Results
A detailed look at Palladyne AI’s fiscal 2025 numbers, backlog and capital structure after the latest annual report and guidance update.
BigBear.ai Holdings Inc ( $BBAI ) Q4 2025 reset, cash arsenal & 2026 AI-defense roadmap
The company prints a sharp revenue decline but a much narrower net loss, closes Ask Sage and CargoSeer, and walks into 2026 with over $460 million in cash and investments — at the price of massive dilution and a complex capital structure. Retail is back in the name, but the story is anything but low-risk.
IREN Ltd ( $IREN )
IREN Limited, formerly Iris Energy, is rapidly transforming itself from a cyclical Bitcoin miner into a vertically integrated AI infrastructure provider, combining long-duration power contracts, hyperscale data centres and multi-year GPU cloud deals with blue-chip counterparties. The next phase of the story is all about execution: how fast the company can switch its asset base to AI, how stable those cloud revenues become and how it balances growth ambitions with leverage and dilution.
BigBear.ai Holdings Inc ( $BBAI )
BigBear.ai is trying to turn years of work in defense intelligence, mission planning and logistics optimization into a scalable AI platform story, boosted by large capital raises and the acquisition of generative-AI partner Ask Sage. Revenues are meaningful and the cash cushion is large, but the path from contract wins to durable, profitable growth remains complex and execution-dependent.
POET Technologies Inc ( $POET ) 2025–2026 Capital Ramp
Updated overview of POET Technologies after the 2025 production orders, equity financings and the 2026 Lightwave award: technology, product line, financial profile, partnerships, retail sentiment and key risk factors.
SoundHound AI Inc ($SOUN)
SoundHound AI started as a voice and music-recognition company and gradually evolved into a broader conversational-AI provider. It now positions itself as a global platform for voice and agentic AI, powering restaurant phone ordering and drive-thrus, in-car voice assistants, smart devices and enterprise customer-service agents across financial services, healthcare, retail and more.
Rackspace Technology (RXT) – AI Turnaround Story After the Palantir Partnership
Rackspace Technology (NASDAQ: RXT) is a heavily leveraged hybrid multicloud and managed services provider that is trying to reposition itself as an “AI-first” infrastructure and operations partner. After years of revenue decline, recurring losses and a difficult competitive landscape, the February 18, 2026 strategic partnership with Palantir has triggered a violent rerating of the stock and reopened the turnaround debate.
War Ai and the X Ecosystem
SpaceX launches satellites, Starlink keeps front lines online, X shapes the information space, and xAI’s Grok is being wired into military networks. A new Pentagon contest for voice-controlled autonomous drones shows how these pieces are starting to lock together into a single, highly political war-tech stack.
AI in Biotech 2026 $RXRX $TEM $EXAI
Recursion, Tempus AI and Exscientia are three “pure-play” examples of what it really means to put artificial intelligence at the centre of a biotech business model. Used properly, AI can compress timelines, surface non-obvious biology and make better use of messy data. Used badly, it can amplify errors, burn cash faster and create stories the clinic will never confirm.
Top 10 AI Mid & Small Cap Stocks for 2026
The logic of this basket is to follow the AI value chain from data to models to deployment, without touching the mega-cap hyperscalers. Each ticker is plugged into a different piece of that chain: some provide platforms, some sell services, some sell hardware that enables AI workloads.
AI disruption 2026 – winners, losers and what it really means for people
The core idea is blunt but useful: markets are paying up for the “picks and shovels” of AI – chips, foundry, high-bandwidth memory, data centres, cybersecurity, observability – and they are putting a heavy discount on businesses whose main value proposition can be replicated by AI agents, plug-ins and low-cost automation. It is not just about which tickers are in fashion; it is about which roles and workflows are becoming cheaper to automate.
BKSY BlackSky Technology
Small-cap geospatial intelligence pure play with a fast-growing Gen-3 satellite constellation, recurring U.S. and international defense contracts and strong leverage to the new U.S. space and missile-defense cycle.
BBAI BigBear.ai Holdings Inc
BigBear.ai started as a data-fusion and analytics contractor, grew via acquisitions and went public through the GigCapital4 SPAC at the end of 2021. The company’s value proposition is to make sense of messy data streams and provide actionable recommendations for operators in defense, intelligence, border security, logistics and other complex environments. To do that, it combines traditional analytics, AI/ML models, simulation, and mission-planning tools into a single decision-intelligence laye
2026 The New Era – Watchlist Space-AI-Defense
2026 opens in a geopolitical environment that looks like a “Cold War 2.0” – but running at a much higher speed and across more domains than anything we have seen before. Classic threat pillars – nuclear deterrence, air and sea control, conventional superiority – are still there, but they have been reshaped by disruptive technologies that make them far more lethal and unpredictable.
POET Technologies Inc Jan Recap
January 2026 has been anything but quiet for POET Technologies. The stock first extended the late-2025 rerating on the “AI optics” narrative and then got hit hard by a US$150 million registered direct offering that erased most of the month’s gains. The industrial thesis around the Optical Interposer has not changed, but the share count has – and the market is repricing that.